Published in Gene Therapy Weekly, November 23rd, 2000
In conjunction with the merger, Cardiogene is changing its name to Cardion AG to reflect the broadening of its product portfolio and repository of technology platforms. The combined entity will retain corporate headquarters in Erkrath, Germany, and establish U.S. operations in Boston, Massachusetts.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.